For a newborn with trisomy 18, which care focus is most appropriate?

For a newborn with trisomy 18, which care focus is most appropriate?

• A. Aggressive curative surgeries
• B. Experimental therapies
• C. Comfort measures and quality of life
• D. Routine immunizations only

Answer: (C)

For a newborn with trisomy 18, the focus is on comfort and quality of life because Edwards syndrome often involves severe, life-limiting anomalies and a poor prognosis. In this context, the goal of care is to relieve suffering and support both the infant and the family, rather than pursue invasive cures. This means prioritizing symptom relief, gentle handling, and interventions that ease distress—such as effective pain control, airway and respiratory comfort, feeding support tailored to the infant’s tolerance, and skin and comfort care. The care team also helps the family understand the prognosis and align decisions with their values, preferences, and the infant’s best interests. Aggressive curative surgeries are typically not pursued because they are unlikely to meaningfully improve overall outcomes and can add burdensome procedures and suffering. Experimental therapies lack established benefit in this setting and are not standard of care for modifying the course of trisomy 18 in a neonate. Routine immunizations, while part of well-child care in many situations, are not the primary aim in a palliative neonatal approach when comfort and quality of life are the priorities.

For a newborn with trisomy 18, the focus is on comfort and quality of life because Edwards syndrome often involves severe, life-limiting anomalies and a poor prognosis. In this context, the goal of care is to relieve suffering and support both the infant and the family, rather than pursue invasive cures. This means prioritizing symptom relief, gentle handling, and interventions that ease distress—such as effective pain control, airway and respiratory comfort, feeding support tailored to the infant’s tolerance, and skin and comfort care. The care team also helps the family understand the prognosis and align decisions with their values, preferences, and the infant’s best interests.

Aggressive curative surgeries are typically not pursued because they are unlikely to meaningfully improve overall outcomes and can add burdensome procedures and suffering. Experimental therapies lack established benefit in this setting and are not standard of care for modifying the course of trisomy 18 in a neonate. Routine immunizations, while part of well-child care in many situations, are not the primary aim in a palliative neonatal approach when comfort and quality of life are the priorities.